roxatidine acetate has been researched along with Esophageal Reflux in 3 studies
roxatidine acetate: structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "The diagnosis of GERD was established by the method of Los Angeles classification including mucosal minimum change of Grade M and questionnaire for the diagnosis of reflux disease (QUEST) score." | 6.72 | A proton pump inhibitor, lansoprazole, ameliorates asthma symptoms in asthmatic patients with gastroesophageal reflux disease. ( Dobashi, K; Ishizuka, T; Kawamura, O; Kobayashi, S; Kusano, M; Mori, M; Ohki, I; Shimizu, Y; Shimoyama, Y; Sunaga, N; Tokushima, M; Utsugi, M, 2006) |
| "A total of 3409 patients with gastro-oesophageal reflux disease were treated with roxatidine acetate." | 3.69 | [Roxatidine acetate in therapy of reflux esophagitis]. ( Botzler, R; Friedrich, P; Kriech, W; Mayershofer, R, 1996) |
| "The diagnosis of GERD was established by the method of Los Angeles classification including mucosal minimum change of Grade M and questionnaire for the diagnosis of reflux disease (QUEST) score." | 2.72 | A proton pump inhibitor, lansoprazole, ameliorates asthma symptoms in asthmatic patients with gastroesophageal reflux disease. ( Dobashi, K; Ishizuka, T; Kawamura, O; Kobayashi, S; Kusano, M; Mori, M; Ohki, I; Shimizu, Y; Shimoyama, Y; Sunaga, N; Tokushima, M; Utsugi, M, 2006) |
| " The ideal therapy for GORD will have linear pharmacokinetics, a relatively long plasma half-life (t1/2), a duration of action allowing once daily administration, and a stable effect independent of interactions with food, antacids and other drugs." | 2.39 | Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease. ( Berstad, A; Hatlebakk, JG, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimizu, Y | 1 |
| Dobashi, K | 1 |
| Kobayashi, S | 1 |
| Ohki, I | 1 |
| Tokushima, M | 1 |
| Kusano, M | 1 |
| Kawamura, O | 1 |
| Shimoyama, Y | 1 |
| Utsugi, M | 1 |
| Sunaga, N | 1 |
| Ishizuka, T | 1 |
| Mori, M | 1 |
| Friedrich, P | 1 |
| Botzler, R | 1 |
| Mayershofer, R | 1 |
| Kriech, W | 1 |
| Hatlebakk, JG | 1 |
| Berstad, A | 1 |
1 review available for roxatidine acetate and Esophageal Reflux
| Article | Year |
|---|---|
Pharmacokinetic optimisation in the treatment of gastro-oesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Antacids; Benzimidazoles; Cimetidine; Cisapride; Domperidon | 1996 |
1 trial available for roxatidine acetate and Esophageal Reflux
| Article | Year |
|---|---|
A proton pump inhibitor, lansoprazole, ameliorates asthma symptoms in asthmatic patients with gastroesophageal reflux disease.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Administration, Oral; Adult; Aged; Asthma; Drug Evaluation; | 2006 |
1 other study available for roxatidine acetate and Esophageal Reflux
| Article | Year |
|---|---|
[Roxatidine acetate in therapy of reflux esophagitis].
Topics: Anti-Ulcer Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Esophagoscopy; Fe | 1996 |